Analyst upgrades typically lead to a positive short-term reaction in the stock market as they reflect an improved outlook on the company's future performance and financial health. Given the upgrade from Mixed to Positive by OTR Global, it's likely that investor sentiment will improve, potentially driving up the stock price of Edwards Lifesciences in the short term.